Isabel Kalofonos's Insider Trades & SAST Disclosures

Isabel Kalofonos's most recent trade in Crinetics Pharmaceuticals Inc was a trade of 55,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 23, 2026.

Share

Note

This is a custom search result for pattern Isabel Kalofonos.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Crinetics Pharma Inc	Isabel Kalofonos	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Feb 2026	55,000	55,000	-		-	Stock Option (Right to Buy)
Crinetics Pharma Inc	Isabel Kalofonos	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Feb 2026	34,000	34,834 (0%)	0%		0	Common Stock
Crinetics Pharma Inc	Isabel Kalofonos	Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.59 per share.	05 Jan 2026	2,500	3,334 (0%)	0%	40.6	101,475	Common Stock
Crinetics Pharma Inc	Isabel Kalofonos	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 55.00 per share.	05 Jan 2026	2,500	834 (0%)	0%	55	137,500	Common Stock
Crinetics Pharma Inc	Isabel Kalofonos	Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Jan 2026	2,500	97,500	-		-	Stock Option (Right to Buy)
Crinetics Pharma Inc	Isabel Kalofonos	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	100,000	100,000	-		-	Stock Option (Right to Buy)
Immunogen Inc 10-year high	Isabel Kalofonos	SVP & CHIEF COMMERCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2023	284,250	284,250	-		-	Stock Option (Right to Buy)
Immunogen Inc 10-year high	Isabel Kalofonos	SVP & CHIEF COMMERCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2023	47,375	47,375	-		-	Restricted Stock Unit

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades